Analysts Set Johnson Matthey PLC (LON:JMAT) PT at GBX 1,985

Johnson Matthey PLC (LON:JMATGet Free Report) has received a consensus rating of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is GBX 1,985 ($25.09).

JMAT has been the subject of a number of recent analyst reports. Numis Securities reissued a “buy” rating and issued a GBX 2,200 ($27.80) price objective on shares of Johnson Matthey in a research report on Wednesday, March 20th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 2,100 ($26.54) price objective on shares of Johnson Matthey in a research report on Wednesday, March 20th.

Read Our Latest Analysis on JMAT

Johnson Matthey Stock Down 0.3 %

Shares of Johnson Matthey stock opened at GBX 1,789 ($22.61) on Monday. Johnson Matthey has a 52-week low of GBX 1,428.50 ($18.05) and a 52-week high of GBX 2,016.50 ($25.48). The firm’s 50 day moving average price is GBX 1,653.86 and its 200-day moving average price is GBX 1,615.60. The company has a quick ratio of 0.76, a current ratio of 1.51 and a debt-to-equity ratio of 63.95. The company has a market cap of £3.28 billion, a P/E ratio of 1,863.54, a PEG ratio of 49,242.50 and a beta of 0.96.

Insider Buying and Selling

In related news, insider Stephen Oxley acquired 24 shares of the firm’s stock in a transaction dated Wednesday, January 17th. The stock was acquired at an average price of GBX 1,585 ($20.03) per share, with a total value of £380.40 ($480.73). Insiders acquired a total of 66 shares of company stock valued at $109,920 over the last 90 days. Insiders own 0.57% of the company’s stock.

About Johnson Matthey

(Get Free Report

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Recommended Stories

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.